News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
41,499 Results
Type
Article (2692)
Company Profile (25)
Press Release (38781)
Multimedia
Podcasts (14)
Webinars (2)
Section
Business (15997)
Career Advice (78)
Deals (2143)
Drug Delivery (10)
Drug Development (4191)
Employer Resources (10)
FDA (459)
Job Trends (789)
News (20389)
Policy (1066)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Standard (1)
Academia (146)
ADA (4)
Allergies (8)
Alliances (3491)
ALS (7)
Alzheimer's disease (77)
Antibody-drug conjugate (ADC) (58)
Approvals (472)
Artificial intelligence (52)
ASCO (16)
Autoimmune disease (34)
Automation (5)
Bankruptcy (13)
Best Places to Work (477)
BIO (12)
BIOSECURE Act (2)
Biosimilars (24)
BioSpace Insights (12)
Biotechnology (17)
Bladder cancer (10)
Brain cancer (9)
Breast cancer (61)
Cancer (452)
Cardiovascular disease (15)
Career advice (66)
Career pathing (1)
CAR-T (49)
CDC (2)
CDMO (6)
Cell therapy (111)
Cervical cancer (7)
Clinical research (3634)
Collaboration (269)
Company closure (4)
Compensation (149)
Complete response letters (1)
COVID-19 (186)
CRISPR (12)
C-suite (187)
Cystic fibrosis (8)
Data (635)
Denatured (6)
Depression (12)
Dermatology (1)
Diabetes (26)
Diagnostics (509)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (55)
Drug pricing (10)
Duchenne muscular dystrophy (65)
Earnings (4757)
Editorial (6)
Employer branding (1)
Employer resources (8)
Events (6686)
Executive appointments (161)
FDA (667)
Friedreich's ataxia (8)
Frontotemporal dementia (1)
Funding (237)
Gene editing (42)
Generative AI (3)
Gene therapy (78)
GLP-1 (80)
Government (163)
Guidances (25)
Healthcare (730)
Hematology (8)
HIV (3)
Huntington's disease (6)
IgA nephropathy (16)
Immunology and inflammation (44)
Immuno-oncology (19)
Indications (12)
Infectious disease (209)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (9)
Intellectual property (42)
Interviews (7)
IPO (1011)
IRA (7)
Job creations (293)
Job search strategy (62)
JPM (4)
Kidney cancer (12)
Labor market (12)
Layoffs (54)
Leadership (3)
Legal (218)
Licensing (1)
Liver cancer (6)
Longevity (6)
Lung cancer (43)
Lymphoma (16)
Machine learning (4)
Management (4)
Manufacturing (86)
MASH (19)
Medical device (316)
Medtech (321)
Mergers & acquisitions (1272)
Metabolic disorders (104)
mRNA (14)
Multiple sclerosis (28)
Neurodegenerative disease (43)
Neuropsychiatric disorders (15)
Neuroscience (221)
NextGen: Class of 2026 (354)
Non-profit (160)
Now hiring (15)
Obesity (49)
Opinion (23)
Ovarian cancer (28)
Pain (37)
Pancreatic cancer (28)
Parkinson's disease (16)
Partnered (4)
Patents (71)
Patient recruitment (60)
Peanut (1)
People (6056)
Pharmaceutical (2)
Phase 1 (1567)
Phase 2 (1789)
Phase 3 (964)
Pipeline (857)
Policy (17)
Postmarket research (30)
Preclinical (670)
Press Release (2)
Prostate cancer (8)
Psychedelics (6)
Radiopharmaceuticals (20)
Rare diseases (101)
Real estate (425)
Recruiting (5)
Regulatory (1011)
Reports (7)
Research institute (149)
Resumes & cover letters (9)
Rett syndrome (4)
RNA editing (5)
RSV (3)
Schizophrenia (18)
Series A (61)
Series B (29)
Sickle cell disease (4)
Special edition (3)
Spinal muscular atrophy (3)
Sponsored (1)
Startups (505)
Stomach cancer (3)
Supply chain (7)
Tariffs (2)
The Weekly (8)
Vaccines (72)
Venture capital (21)
Weight loss (29)
Women's health (25)
Worklife (1)
Date
Today (11)
Last 7 days (38)
Last 30 days (200)
Last 365 days (2417)
2026 (1624)
2025 (2440)
2024 (2594)
2023 (2860)
2022 (3750)
2021 (4045)
2020 (3466)
2019 (2059)
2018 (1552)
2017 (1798)
2016 (1622)
2015 (1849)
2014 (1375)
2013 (1189)
2012 (1395)
2011 (1333)
2010 (1177)
Location
Africa (43)
Alabama (3)
Arizona (21)
Asia (2022)
Australia (310)
California (2136)
Canada (328)
China (120)
Colorado (78)
Connecticut (21)
Delaware (15)
Europe (4140)
Florida (78)
Georgia (20)
Hawaii (2)
Idaho (3)
Illinois (31)
India (6)
Indiana (76)
Japan (24)
Kansas (16)
Kentucky (1)
Louisiana (2)
Maryland (78)
Massachusetts (778)
Michigan (15)
Minnesota (32)
Mississippi (1)
Missouri (6)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (185)
New York (115)
North Carolina (167)
Northern California (1102)
Ohio (64)
Oklahoma (2)
Oregon (6)
Pennsylvania (149)
Puerto Rico (1)
Rhode Island (4)
South America (40)
South Carolina (2)
Southern California (866)
Tennessee (6)
Texas (204)
United States (4308)
Utah (7)
Virginia (15)
Washington D.C. (3)
Washington State (115)
West Virginia (1)
Wisconsin (20)
41,499 Results for "sanguine biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sanguine Biosciences Expands Clinical Biospecimen Portfolio With New Synovial Fluid and Skin Punch Biopsy Offerings
December 4, 2025
·
3 min read
Biotech Beach
Sanguine Biosciences Affirms Superior Quality of its Biospecimen Services Using VERIF.i®, Scientist.com’s Supplier Pre-assessment Program
Sanguine Biosciences Affirms Superior Quality of its Biospecimen Services Using VERIF.i ® , Scientist.com’s Supplier Pre-assessment Program.
April 9, 2024
·
3 min read
Mergers & acquisitions
Argenx deepens immuno expertise with $2.2B Forte Biosciences buy
The star of the takeover is Forte Biosciences’ investigational antibody therapy, FB102, which has shown early potential in vitiligo and celiac disease.
July 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Sanguine Biosciences Announces the Launch of LeukoCert™ GMP Leukopaks
November 5, 2024
·
3 min read
Genetown
Sanguine Biosciences Adds Advanced Health Data Integration Capabilities that Further Enhance Translational Medical Research
Sanguine Biosciences announced advanced capabilities in acquiring and integrating electronic health records with donor specimens, further advancing its commitment to empowering patients to participate in medical research.
January 8, 2024
·
3 min read
Genetown
Sanguine Biosciences Announces $10 Million Credit Financing from Catalio Capital Management to Fund Continued Growth
Sanguine Biosciences today announced that it secured $10 million in credit financing from Catalio Capital Management, a leading multi-strategy healthcare and life science investment firm.
October 31, 2023
·
3 min read
Genetown
Sanguine Biosciences Opens New Apheresis Donor Center to Support Cell & Gene Therapy and Translational Research Initiatives
Sanguine Biosciences, a leader in connecting patients with biomedical researchers to accelerate precision medicine R&D, announced its opening of a blood donor center in Los Angeles, California.
September 13, 2023
·
4 min read
Press Releases
Daré Bioscience’s Sildenafil Cream Data in Postmenopausal Women Published in Menopause - The Journal of The Menopause Society
August 26, 2026
·
13 min read
Press Releases
Jade Biosciences to Participate in Upcoming Conferences
September 1, 2026
·
4 min read
Press Releases
argenx Completes Acquisition of Forte Biosciences, Inc.
August 27, 2026
·
6 min read
1 of 4,150
Next
